Valeant Pharma (VRX) November weekly 19 straddle priced for movement of 17% into Q3
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Valeant Pharma (NYSE: VRX) November weekly 19 straddle priced for movement of 17% into Q3
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix, Inc. (NFLX) volatility elevated, shares near record high into Q4
- BB& T (BBT) call put ratio 3 calls to 1 put into Q4
- Stocks with Implied Volatility Movement
Create E-mail Alert Related CategoriesOptions, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!